Blog | News | Updates

FDA warns Mylan over quality violations at Indian factory

In the last 10 years, remarkable advances have been made in how we fight cancer, work that was made possible by our nation’s support of biomedical research, largely through the National Institutes of Health. One of the most powerful new tools in our arsenal is cancer immunotherapy, which reawakens the body’s own immune system. Immunotherapy drugs have produced stunning results for many people suffering from advanced cancer.

Cancer drugs known as immune checkpoint inhibitors unleash the body’s immune cells to attack tumors. And for some patients in whom the drugs seemingly fail, there actually is an immune response — it’s just not powerful enough to kill off cancer cells. Researchers have found a new way to predict which patients will have a response, however small, and hope it’ll give clinicians a way to strike while the iron is hot with combination therapies that might improve outcomes. Here’s what microbiologist John Wherry of the University of Pennsylvania said about the work, published in Nature. We wanted to use …